MTOR and cancer: However, recent publications have found that pharmacological suppression of mTOR activity in cancer cells can cause chemoresistant cell populations to persist through regulation of autophagy and G2/M cell cycle arrest; mTOR activation can increase chemosensitivity and predict better survival64,65.